BENDHEIM JACK (President and CEO) sold 7.1% of their position (3.52K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $147.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 11/24/2025ACC: 0001104659-25-115420
DirectorOfficer10% Owner· President and CEO
Since Jul 2018
-3.52K
Net shares
Net seller
$147.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
3.52K disposed
Non-Derivative Transactions2
Class A Common Stock
Indirect
Shares
−3.46K
Price / share
$41.75
Trade value
$144.42K
% of position
7.0%
11/20/2025
49.68K→46.22K
Class A Common Stock
Indirect
Shares
−61.00
Price / share
$42.32
Trade value
$2.58K
% of position
0.1%
11/20/2025
46.22K→46.16K
Total
Net shares
−3.52K
Net value
-$147K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 11/20/2025 | S · Sale | −3.46K | $41.75 | $144.42K | 7.0% | 49.68K | 46.22K |
| Class A Common Stock Indirect | 11/20/2025 | S · Sale | −61.00 | $42.32 | $2.58K | 0.1% | 46.22K | 46.16K |
| Total | −3.52K | -$147K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Common Stock
DirectShares owned16.84K
Total
16.84K direct16.84K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 16.84K | Direct |
| Total | 16.84K | 16.84K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported